![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Alderman B., Thelwall-Jones H. Application of the potentiating effect of prostaglandin E2, and oxytocin to induce second trimester abortion. Journal of Obstetrics and Gynaecology of the British Commonwealth 1973; 80: 1021–1024
- Brummer H. C. Further studies on the interaction between prostaglandins and syntocinon on the isolated pregnant human myometrium. Journal of Obstetrics and Gynaecology of the British Commonwealth 1972; 79: 526–530
- Conrad J. T., Ueland K. Reduction of the stretch modulus of human cervical tissue by prostaglandin E2. American Journal of Obstetrics and Gynecology 1976; 126: 218–223
- Embrey M. P., Hillier K. Therapeutic abortion by intrauterine instillation of prostaglandins. British Medical Journal 1971; i: 588–590
- Embrey M. P., Hillier K., Mahendran P. Induction of abortion by extra-amniotic administration of prostaglandins E2, and F2a. British Medical Journal 1972; iii: 146–149
- Filshie G. M., Ahluwalia J., Beard R. W. Portable Karman curette equipment in management of incomplete abortions. Lancet 1973; ii: 1114–1116
- Gillespie A. Prostaglandin-oxytocin. Enhancement and potentiation and their clinical applications. British Medical Journal 1972; i: 150–152
- Kajanoja P., Jungner G., Seppålä M., Karjalainen O., Widholm O. Prostaglandin induction of midtrimester abortions: three years' experience of 626 cases. Acta Obstetrica et Gynecologica Scandinavica supplement 1975; 37: 51–56
- Karim S. M. M., Filshie G. M. Use of prostaglandin E2, for therapeutic abortion. British Medical Journals 1970; iii: 198–200
- Lauersen N. H. Investigation of prostaglandins for abortion. Acta Obstetrica et Gynecologica Scandinavica supplement 1979; 81: 11–29
- Lippes J., Hurd M. The use of chlorpromazine and lomotil and to prevent and/or reduce the side effects of prostaglandin E2 used for abortion. Contraception 1975; 12: 569–577
- Mackenzie I. Z., Hillier K., Embrey M. P. Single extra-amniotic injection of prostaglandin E2 in viscous gel to induce mid-trimester abortion. British Medical Journal 1975; i: 240–242
- Mackenzie I. Z., Hillier K. Prostaglandin-induced abortion and outcome of subsequent pregnancies: a prospective controlled study. British Medical Journal 1977; ii: 1114–1117
- Miller A. W. F., Calder A. A., MacNaughton M. C. Termination of pregnancy by continuous intra-uterine infusion of prostaglandins. Lancet 1972; i: 5–7
- Morewood G. A. Therapeutic abortion employing the synergistic action of extra-amniotic prostaglandin E and an intravenous infusion of oxytocin. Journal of Obstetrics and Gynaecology of the British Commonwealth 1973; 80: 473–475
- Roberts G., Cassie R., Turnbull A. C. Therapeutic abortion by intrauterine instillation of prostaglandin E2. Journal of Obstetrics and Gynaecology of the British Commonwealth 1971; 78: 834–837